AGE Reader

Non-invasive cardiovascular risk assessment

Patient friendly diagnosis, Personalized care & Preventing disease

Wish to receive a quotation on product purchasing or leasing? Quotation request

AGE Reader in patient management

The AGE Reader assists physicians in focusing treatment on patients with the highest risk of complications. This includes patients suffering from diabetes mellitus, renal failure but also acute disorders like acute coronary syndromes and sepsis.

The non-invasive AGE Reader measurement adds value particularly to the classic risk factors that predict the cardiovascular risk of diabetes patients. The AGE Reader measurement reflects the glycometabolic memory which is not covered by the classic risk markers. Therefore it adds clinically relevant information to the cardiovascular risk prediction for diabetes patients.

In diabetes patients the AGE Reader:

  • Reflects the vascular damage of a patient.
  • Identifies diabetes patients at risk of developing cardiovascular and/or micro-vascular complications.
  • is a cost-effective assessment tool that adds clinical value to conventional risk engines.

Applications of the AGE Reader

The information of the AGE Reader measurement is especially interesting for the following applications:

  • A motivation tool for patients.
  • Assist in clinical decision making about intensifying or changing treatment of diabetes patients, such as switching to more intensive diabetes treatments or multiple therapy.
  • Assist in clinical decision making about the cut-off levels for classic cardiovascular risk markers.
  • Identify patients with an increased risk of developing complications that were identifiable based on the classic cardiovascular risk markers.

Interested in receiving a white paper and product brochure? Please leave your name and email here.

More Information
Request information

Would you like to learn more about our products? Request any information you wish to receive here.

The AGE Reader App!
The new AGE Reader App allows you to generate a comprehensive Cardiovascular Risk Report based on the AGE Reader measurement. For each patient all visits can be documented and consulted in the easy to use App.
Read more »
About the company

More information about Diagnoptics.

Information for patients

Information on Diagnoptics' products and Advanced Glycation Endproducts.

Information for professionals

Information about Advanced Glycation Endproducts, the AGE measurement and clinical validation.